143 related articles for article (PubMed ID: 9021740)
1. Antisense technology and prospects for therapy of viral infections and cancer.
Wagner RW; Flanagan WM
Mol Med Today; 1997 Jan; 3(1):31-8. PubMed ID: 9021740
[TBL] [Abstract][Full Text] [Related]
2. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Sommer W; Heilig M
Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide-based therapeutics for cancer.
Dean NM; Bennett CF
Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotide therapy in urology.
Kausch I; Böhle A
J Urol; 2002 Jul; 168(1):239-47. PubMed ID: 12050550
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide therapeutics: clothing the emperor.
Gewirtz AM
Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide technology: from EST to therapeutics.
Giles RV
Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide therapy in cancer.
Stephens AC; Rivers RP
Curr Opin Mol Ther; 2003 Apr; 5(2):118-22. PubMed ID: 12772500
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
10. Antisense therapy in malignant diseases: status quo and quo vadis?
Tamm I
Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947
[TBL] [Abstract][Full Text] [Related]
11. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
Oberbauer R
Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
[TBL] [Abstract][Full Text] [Related]
12. [Prospects for antisense therapy].
Maekawa T
Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
[TBL] [Abstract][Full Text] [Related]
13. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
14. [Applications of antisense oligonucleotides in oncology].
Pierga JY; Cammilleri S; Benyahia B; Magdelénat H
Bull Cancer; 1994 Dec; 81(12):1023-42. PubMed ID: 7742591
[TBL] [Abstract][Full Text] [Related]
15. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide pharmacotherapy: an antigene strategy.
Nagel KM; Holstad SG; Isenberg KE
Pharmacotherapy; 1993; 13(3):177-88. PubMed ID: 8321732
[TBL] [Abstract][Full Text] [Related]
17. Synthetic oligonucleotides as therapeutics: the coming of age.
Ma DD; Rede T; Naqvi NA; Cook PD
Biotechnol Annu Rev; 2000; 5():155-96. PubMed ID: 10875000
[TBL] [Abstract][Full Text] [Related]
18. [Development of antisense nucleotides for therapy].
Wang J; Wang L; Wang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides and prevention of tumor growth: a different approach and proposal for a new method.
Yildiz D; Oztas H; Hilal Ates B
Med Hypotheses; 2005; 64(2):328-32. PubMed ID: 15607566
[TBL] [Abstract][Full Text] [Related]
20. Antisense strategy in hematological malignancies.
Warzocha K
Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
